Multidrug-Resistant Gram-Positive Pathogens
- 1 January 1997
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 54 (6) , 11-20
- https://doi.org/10.2165/00003495-199700546-00005
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide‐resistant enterococciMolecular Microbiology, 1996
- Reducing the Spread of Antimicrobial-Resistant Microorganisms: Control of Vancomycin-Resistant EnterococciPediatric Clinics of North America, 1995
- Anti-infective treatment in intensive care: The role of glycopeptidesIntensive Care Medicine, 1994
- Hospital-acquired infections: diseases with increasingly limited therapies.Proceedings of the National Academy of Sciences, 1994
- Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureusFEMS Microbiology Letters, 1992
- Detection of glycopeptide resistance in clinical isolates of Gram-positive bacteriaJournal of Antimicrobial Chemotherapy, 1991
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobialJournal of Antimicrobial Chemotherapy, 1990
- The effect of medium and inoculum on the actirity of vancomycin and teicoplanin against coagulase-negative staphylococciJournal of Antimicrobial Chemotherapy, 1987